Key Highlights

  • The U.S. Commerce Department is awarding $2 billion to nine Quantum Computing firms, with government Equity stakes attached to each deal.
  • IBM receives $1 billion to establish Anderon, a standalone 300-millimeter quantum wafer foundry in Albany, New York.
  • GlobalFoundries receives $375 million; D-Wave Quantum, Rigetti Computing, and Infleqtion are each allocated $100 million.
  • Funding originates from the 2022 Chips and Science Act, extending Washington's strategic ownership model beyond semiconductors.
  • Quantum stocks surged 7% to 23% in premarket trading on Thursday after the Wall Street Journal broke the story.

The United States government has never been comfortable sitting on the sidelines of a technology race it believes it cannot afford to lose. On Thursday, it made that position explicit. The Trump administration is awarding $2 billion in grants to nine quantum computing companies, with the U.S. Commerce Department taking equity stakes in each firm as part of the arrangement. The Wall Street Journal first reported the development, citing the Commerce Department directly.

This is not a conventional research Subsidy. It is a ownership play dressed in the language of industrial policy, and it fits a pattern that is becoming increasingly familiar in Washington.

A Template Already in Motion

Before quantum computing entered this framework, Washington deployed the same model in semiconductors and critical minerals. The administration has already taken significant ownership positions in Intel (Nasdaq:INTC) and MP Materials (NYSE:MP), the rare earth Mining company, framing equity participation not as market interference but as Supply chain security. The logic is consistent: in sectors where China poses a credible competitive or strategic threat, the United States government intends to be a stakeholder, not merely a regulator.

Quantum computing is the newest addition to that list. The technology harnesses quantum mechanical principles to process certain classes of complex problems at speeds that classical computers cannot match. The long-term applications span cryptography, drug discovery, financial modelling, and logistics optimisation. The near-term reality is more constrained: existing quantum machines dedicate a large share of their processing capacity to error correction, which means they do not yet outperform classical computers in practical deployments. The commercial timeline remains genuinely uncertain.

That uncertainty has not deterred the Capital commitment. Infrastructure built today shapes who leads the industry when practical quantum advantage eventually arrives.

IBM Gets the Largest Allocation

IBM (NYSE:IBM) is the headline recipient, receiving $1 billion from the Commerce Department. The company confirmed it will use the award to create Anderon, a new standalone company that will operate as America's first purpose-built quantum wafer foundry. Headquartered in Albany, New York, Anderon will function as a 300-millimeter Facility producing quantum wafers not just for IBM but for a broad range of external companies seeking access to quantum fabrication capacity.

IBM is matching the federal allocation with $1 billion of its own capital, bringing total committed Investment to $2 billion for the foundry alone. The economic ambition behind the project is stated plainly: the quantum computing industry is estimated to generate up to $850 billion in economic value by 2040. The Anderon foundry is IBM's bid to sit at the center of that ecosystem, capturing foundry Revenue the way TSMC has in classical semiconductors.

Seeding the Broader Ecosystem

The remaining allocations follow a tiered structure that reflects both commercial scale and strategic function. Chipmaker GlobalFoundries (NASDAQ:GFS) receives $375 million, acknowledging its role in advanced semiconductor fabrication processes directly relevant to quantum hardware Manufacturing. Three pure-play quantum firms, D-Wave Quantum (NYSE:QBTS), Rigetti Computing (NASDAQ:RGTI), and Infleqtion (NYSE:INFQ), are each expected to receive $100 million. Startup Diraq is reportedly in line for $38 million.

The deals remain subject to formal completion. All funding flows from the Chips and Science Act, the 2022 legislation that created the primary federal instrument for intervening in semiconductor and advanced computing supply chains.

The Equity Model and Its Complications

Taking equity stakes rather than issuing straightforward grants changes the relationship between government and industry in ways that extend well beyond the initial capital transfer. The government becomes simultaneously a regulator, a funder, and a Shareholder in the same companies. It assumes upside if the technology delivers, but it also acquires a governance interest in firms whose competitive decisions it may one day need to adjudicate. That structural tension is not unique to quantum computing, but it intensifies in a sector where IP development, export controls, and national security classification are all in motion at once.

The geopolitical case for accepting that tension is clear. China has made quantum computing a national priority, investing heavily in both research and infrastructure. Whether or not near-term quantum advantage materialises on American soil, the manufacturing capability, the talent pipeline, and the foundry infrastructure established now will define which nation shapes the industry's commercial architecture for decades.

Market Reaction

Equity markets read the announcement as a significant de-risking event for firms that had, until now, operated without a visible federal procurement anchor. Shares in the named companies moved sharply in premarket trading: Infleqtion climbed over 23%, D-Wave advanced approximately 16%, Rigetti gained close to 14%, and IBM rose roughly 7%. The moves reflect a reassessment of revenue visibility rather than a Revaluation of quantum technology itself, investors are pricing in the certainty of federal capital, not a breakthrough in error correction.

Conclusion

Washington's $2 billion quantum commitment is most accurately read as infrastructure policy, not technology optimism. The administration is not betting that quantum advantage is imminent. It is betting that foundries, fabrication capacity, and domestic supply chains built today will prove decisive when the technology matures, regardless of the timeline. The IBM-Anderon model, if successfully executed, positions the United States as the supplier of choice for quantum wafer production globally, a role with durable economic and strategic value.

The risks are real and should not be minimised. Quantum advantage at practical scale is unproven, federal ownership introduces governance complexity, and the Chips and Science Act funding pool is finite. But in a race where the alternative is ceding foundational infrastructure to a strategic competitor, Washington has made its position clear. The capital is deployed. The foundries are being built. Whether the science arrives on schedule is the only question that remains open.